annual EBIT:
$279.17M+$777.25M(+156.05%)Summary
- As of today (May 29, 2025), SRPT annual earnings before interest & taxes is $279.17 million, with the most recent change of +$777.25 million (+156.05%) on December 31, 2024.
- During the last 3 years, SRPT annual EBIT has risen by +$634.59 million (+178.54%).
- SRPT annual EBIT is now at all-time high.
Performance
SRPT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$379.01M-$555.23M(-315.08%)Summary
- As of today (May 29, 2025), SRPT quarterly earnings before interest & taxes is -$379.01 million, with the most recent change of -$555.23 million (-315.08%) on March 1, 2025.
- Over the past year, SRPT quarterly EBIT has dropped by -$424.63 million (-930.92%).
- SRPT quarterly EBIT is now -315.08% below its all-time high of $176.22 million, reached on December 31, 2024.
Performance
SRPT quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$145.46M-$424.63M(-152.11%)Summary
- As of today (May 29, 2025), SRPT TTM earnings before interest & taxes is -$145.46 million, with the most recent change of -$424.63 million (-152.11%) on March 1, 2025.
- Over the past year, SRPT TTM EBIT has dropped by -$199.38 million (-369.81%).
- SRPT TTM EBIT is now -152.11% below its all-time high of $279.17 million, reached on December 31, 2024.
Performance
SRPT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SRPT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +156.1% | -930.9% | -369.8% |
| 3 y3 years | +178.5% | -329.0% | +50.2% |
| 5 y5 years | +140.9% | -9974.8% | +76.5% |
SRPT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +143.8% | -315.1% | +25.1% | -152.1% | +86.2% |
| 5 y | 5-year | at high | +140.9% | -315.1% | +25.1% | -152.1% | +86.2% |
| alltime | all time | at high | +140.9% | -315.1% | +25.1% | -152.1% | +86.2% |
SRPT EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$379.01M(-315.1%) | -$145.46M(-152.1%) |
| Dec 2024 | $279.17M(-156.0%) | $176.22M(+352.7%) | $279.17M(+87.9%) |
| Sep 2024 | - | $38.92M(+111.4%) | $148.55M(+81.9%) |
| Jun 2024 | - | $18.41M(-59.6%) | $81.68M(+51.5%) |
| Mar 2024 | - | $45.61M(+0.0%) | $53.91M(-110.8%) |
| Dec 2023 | -$498.09M(-21.8%) | $45.60M(-263.2%) | -$498.09M(-22.0%) |
| Sep 2023 | - | -$27.95M(+198.5%) | -$638.31M(-25.1%) |
| Jun 2023 | - | -$9.36M(-98.2%) | -$852.05M(-19.2%) |
| Mar 2023 | - | -$506.39M(+435.2%) | -$1.05B(+65.7%) |
| Dec 2022 | -$636.72M(+79.1%) | -$94.62M(-60.9%) | -$636.72M(-1.7%) |
| Sep 2022 | - | -$241.68M(+14.0%) | -$647.94M(+47.9%) |
| Jun 2022 | - | -$212.06M(+140.0%) | -$438.17M(+50.0%) |
| Mar 2022 | - | -$88.35M(-16.5%) | -$292.03M(-17.8%) |
| Dec 2021 | -$355.42M(-27.9%) | -$105.84M(+231.7%) | -$355.42M(-15.2%) |
| Sep 2021 | - | -$31.91M(-51.6%) | -$419.34M(-26.4%) |
| Jun 2021 | - | -$65.93M(-56.6%) | -$569.94M(-11.1%) |
| Mar 2021 | - | -$151.74M(-10.6%) | -$641.10M(+30.0%) |
| Dec 2020 | -$493.12M(-27.8%) | -$169.75M(-7.0%) | -$493.12M(-10.3%) |
| Sep 2020 | - | -$182.51M(+33.1%) | -$549.97M(+13.2%) |
| Jun 2020 | - | -$137.09M(+3544.0%) | -$486.03M(-21.3%) |
| Mar 2020 | - | -$3.76M(-98.3%) | -$617.75M(-9.6%) |
| Dec 2019 | -$683.21M(+107.7%) | -$226.60M(+91.1%) | -$683.21M(+15.6%) |
| Sep 2019 | - | -$118.58M(-55.9%) | -$591.03M(+9.7%) |
| Jun 2019 | - | -$268.80M(+288.3%) | -$538.84M(+45.4%) |
| Mar 2019 | - | -$69.22M(-48.5%) | -$370.54M(+12.7%) |
| Dec 2018 | -$328.90M(+668.0%) | -$134.43M(+102.5%) | -$328.90M(+52.4%) |
| Sep 2018 | - | -$66.39M(-33.9%) | -$215.84M(+11.0%) |
| Jun 2018 | - | -$100.50M(+264.3%) | -$194.38M(+24.0%) |
| Mar 2018 | - | -$27.59M(+29.1%) | -$156.76M(+266.0%) |
| Dec 2017 | -$42.83M(-83.9%) | -$21.36M(-52.4%) | -$42.83M(-60.8%) |
| Sep 2017 | - | -$44.92M(-28.6%) | -$109.14M(-9.6%) |
| Jun 2017 | - | -$62.89M(-172.8%) | -$120.75M(+0.8%) |
| Mar 2017 | - | $86.35M(-198.5%) | -$119.85M(-54.9%) |
| Dec 2016 | -$265.37M(+21.4%) | -$87.68M(+55.1%) | -$265.90M(+10.3%) |
| Sep 2016 | - | -$56.53M(-8.8%) | -$241.15M(+2.0%) |
| Jun 2016 | - | -$61.98M(+3.8%) | -$236.38M(+9.2%) |
| Mar 2016 | - | -$59.70M(-5.1%) | -$216.50M(-1.0%) |
| Dec 2015 | -$218.66M(+63.4%) | -$62.93M(+21.6%) | -$218.66M(+9.1%) |
| Sep 2015 | - | -$51.76M(+22.9%) | -$200.45M(+9.9%) |
| Jun 2015 | - | -$42.11M(-31.9%) | -$182.37M(+6.9%) |
| Mar 2015 | - | -$61.86M(+38.3%) | -$170.53M(+27.5%) |
| Dec 2014 | -$133.79M(+48.2%) | -$44.72M(+32.8%) | -$133.79M(+9.7%) |
| Sep 2014 | - | -$33.67M(+11.2%) | -$121.92M(+7.7%) |
| Jun 2014 | - | -$30.27M(+20.5%) | -$113.17M(+13.2%) |
| Mar 2014 | - | -$25.12M(-23.5%) | -$99.99M(+10.8%) |
| Dec 2013 | -$90.28M(+204.0%) | -$32.85M(+31.7%) | -$90.28M(+33.2%) |
| Sep 2013 | - | -$24.93M(+45.9%) | -$67.80M(+36.2%) |
| Jun 2013 | - | -$17.09M(+10.8%) | -$49.77M(+30.1%) |
| Mar 2013 | - | -$15.41M(+48.7%) | -$38.24M(+28.8%) |
| Dec 2012 | -$29.70M(-17.3%) | -$10.37M(+50.1%) | -$29.70M(+4.8%) |
| Sep 2012 | - | -$6.91M(+24.3%) | -$28.34M(-13.4%) |
| Jun 2012 | - | -$5.56M(-19.2%) | -$32.70M(-12.3%) |
| Mar 2012 | - | -$6.87M(-23.6%) | -$37.27M(+3.7%) |
| Dec 2011 | -$35.93M(+71.6%) | -$9.00M(-20.1%) | -$35.93M(+25.3%) |
| Sep 2011 | - | -$11.27M(+11.3%) | -$28.67M(+35.3%) |
| Jun 2011 | - | -$10.13M(+83.1%) | -$21.19M(+13.1%) |
| Mar 2011 | - | -$5.53M(+217.9%) | -$18.73M(-10.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$20.93M(+35.0%) | -$1.74M(-54.2%) | -$20.94M(-9.6%) |
| Sep 2010 | - | -$3.80M(-50.5%) | -$23.16M(+3.9%) |
| Jun 2010 | - | -$7.67M(-0.9%) | -$22.28M(+13.2%) |
| Mar 2010 | - | -$7.74M(+95.4%) | -$19.68M(+26.9%) |
| Dec 2009 | -$15.51M(-11.6%) | -$3.96M(+35.6%) | -$15.51M(+7.4%) |
| Sep 2009 | - | -$2.92M(-42.3%) | -$14.44M(-17.3%) |
| Jun 2009 | - | -$5.07M(+42.1%) | -$17.46M(+1.1%) |
| Mar 2009 | - | -$3.56M(+23.2%) | -$17.28M(-1.5%) |
| Dec 2008 | -$17.54M(-47.0%) | -$2.89M(-51.3%) | -$17.54M(-13.7%) |
| Sep 2008 | - | -$5.94M(+21.7%) | -$20.32M(-11.3%) |
| Jun 2008 | - | -$4.88M(+27.4%) | -$22.89M(-14.8%) |
| Mar 2008 | - | -$3.83M(-32.4%) | -$26.85M(-18.9%) |
| Dec 2007 | -$33.11M(+0.4%) | -$5.67M(-33.4%) | -$33.11M(-8.6%) |
| Sep 2007 | - | -$8.51M(-3.7%) | -$36.21M(+3.5%) |
| Jun 2007 | - | -$8.84M(-12.3%) | -$34.97M(+4.2%) |
| Mar 2007 | - | -$10.09M(+15.0%) | -$33.55M(+1.7%) |
| Dec 2006 | -$32.98M(+88.3%) | -$8.77M(+20.6%) | -$32.98M(+13.3%) |
| Sep 2006 | - | -$7.27M(-2.0%) | -$29.12M(+22.5%) |
| Jun 2006 | - | -$7.42M(-22.1%) | -$23.76M(+10.6%) |
| Mar 2006 | - | -$9.52M(+94.1%) | -$21.49M(+22.7%) |
| Dec 2005 | -$17.52M(-30.1%) | -$4.91M(+155.8%) | -$17.52M(-0.2%) |
| Sep 2005 | - | -$1.92M(-62.8%) | -$17.55M(-15.4%) |
| Jun 2005 | - | -$5.15M(-7.2%) | -$20.75M(-9.1%) |
| Mar 2005 | - | -$5.55M(+12.3%) | -$22.84M(-8.8%) |
| Dec 2004 | -$25.04M(+32.7%) | -$4.94M(-3.6%) | -$25.04M(-8.1%) |
| Sep 2004 | - | -$5.12M(-29.2%) | -$27.27M(+1.7%) |
| Jun 2004 | - | -$7.23M(-6.7%) | -$26.82M(+15.9%) |
| Mar 2004 | - | -$7.75M(+8.3%) | -$23.14M(+22.6%) |
| Dec 2003 | -$18.87M(-25.5%) | -$7.16M(+53.0%) | -$18.87M(+18.9%) |
| Sep 2003 | - | -$4.68M(+31.7%) | -$15.87M(-4.2%) |
| Jun 2003 | - | -$3.55M(+2.1%) | -$16.56M(-20.9%) |
| Mar 2003 | - | -$3.48M(-16.1%) | -$20.93M(-17.4%) |
| Dec 2002 | -$25.34M(+64.5%) | -$4.15M(-22.7%) | -$25.34M(-2.2%) |
| Sep 2002 | - | -$5.37M(-32.2%) | -$25.92M(+8.5%) |
| Jun 2002 | - | -$7.92M(+0.3%) | -$23.89M(+20.9%) |
| Mar 2002 | - | -$7.90M(+66.9%) | -$19.76M(+28.3%) |
| Dec 2001 | -$15.40M(+50.4%) | -$4.73M(+41.5%) | -$15.40M(+9.1%) |
| Sep 2001 | - | -$3.35M(-11.6%) | -$14.12M(+5.6%) |
| Jun 2001 | - | -$3.78M(+6.9%) | -$13.37M(+6.6%) |
| Mar 2001 | - | -$3.54M(+2.5%) | -$12.54M(+22.5%) |
| Dec 2000 | -$10.24M(+23.4%) | -$3.45M(+33.3%) | -$10.24M(+12.7%) |
| Sep 2000 | - | -$2.59M(-12.3%) | -$9.09M(+4.5%) |
| Jun 2000 | - | -$2.96M(+138.2%) | -$8.70M(+13.8%) |
| Mar 2000 | - | -$1.24M(-46.1%) | -$7.64M(-4.5%) |
| Dec 1999 | -$8.30M(+6.4%) | -$2.30M(+4.5%) | -$8.00M(-3.6%) |
| Sep 1999 | - | -$2.20M(+15.8%) | -$8.30M(+5.1%) |
| Jun 1999 | - | -$1.90M(+18.8%) | -$7.90M(+2.6%) |
| Mar 1999 | - | -$1.60M(-38.5%) | -$7.70M(+1.3%) |
| Dec 1998 | -$7.80M(+100.0%) | -$2.60M(+44.4%) | -$7.60M(+26.7%) |
| Sep 1998 | - | -$1.80M(+5.9%) | -$6.00M(+17.6%) |
| Jun 1998 | - | -$1.70M(+13.3%) | -$5.10M(+10.9%) |
| Mar 1998 | - | -$1.50M(+50.0%) | -$4.60M(+24.3%) |
| Dec 1997 | -$3.90M(+77.3%) | -$1.00M(+11.1%) | -$3.70M(+37.0%) |
| Sep 1997 | - | -$900.00K(-25.0%) | -$2.70M(+50.0%) |
| Jun 1997 | - | -$1.20M(+100.0%) | -$1.80M(+200.0%) |
| Mar 1997 | - | -$600.00K | -$600.00K |
| Dec 1996 | -$2.20M | - | - |
FAQ
- What is Sarepta Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual EBIT year-on-year change?
- What is Sarepta Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly EBIT year-on-year change?
- What is Sarepta Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM EBIT year-on-year change?
What is Sarepta Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SRPT is $279.17M
What is the all time high annual EBIT for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual earnings before interest & taxes is $279.17M
What is Sarepta Therapeutics annual EBIT year-on-year change?
Over the past year, SRPT annual earnings before interest & taxes has changed by +$777.25M (+156.05%)
What is Sarepta Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SRPT is -$379.01M
What is the all time high quarterly EBIT for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly earnings before interest & taxes is $176.22M
What is Sarepta Therapeutics quarterly EBIT year-on-year change?
Over the past year, SRPT quarterly earnings before interest & taxes has changed by -$424.63M (-930.92%)
What is Sarepta Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SRPT is -$145.46M
What is the all time high TTM EBIT for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM earnings before interest & taxes is $279.17M
What is Sarepta Therapeutics TTM EBIT year-on-year change?
Over the past year, SRPT TTM earnings before interest & taxes has changed by -$199.38M (-369.81%)